Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's Lymphoma in a child. A case report

Journal of Periodontology

Volumn 72, Issue 1, 2001, Pages 107-112

  Nicolatou Galitis, Ourania ^a   Papadaki, Theodora ^b   Moshovi, Maria ^c   Kamma, Joanna J ^d   Van Vliet Constantinidou, Cathrine ^d   Tsoumakas, Constantine ^c   Kattamis, Antonis ^c   Tzortzatou Stathopoulou, Fotini ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d NONE

Author keywords

Gingival hyperplasia; Hodgkin's lymphoma; Lymphadenopathy, cervical

Indexed keywords

ABVD PROTOCOL; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; MOPP PROTOCOL; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ARTICLE; BIOPSY; CANCER STAGING; CASE REPORT; CHILD; DECIDUOUS TOOTH; GINGIVA HYPERPLASIA; GINGIVA OVERGROWTH; HODGKIN DISEASE; HUMAN; LYMPH NODE; MALE; OSTEOLYSIS; PARANEOPLASTIC SYNDROME; PATHOLOGY; REMISSION; TOOTH DISEASE;

ALVEOLAR BONE LOSS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BLEOMYCIN; CHILD; DACARBAZINE; DOXORUBICIN; GINGIVAL HYPERPLASIA; GINGIVAL OVERGROWTH; HODGKIN DISEASE; HUMANS; LYMPH NODES; MALE; MECHLORETHAMINE; NEOPLASM STAGING; PARANEOPLASTIC SYNDROMES; PREDNISONE; PROCARBAZINE; REMISSION INDUCTION; ROOT RESORPTION; TOOTH, DECIDUOUS; VINBLASTINE; VINCRISTINE;

EID: 0035227273     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2001.72.1.107     Document Type: Article

References (23)

1. Abeloff MD. Paraneoplastic syndromes. A window on the biology of cancer. N Engl J Med 1987;317:1598-1600.
2. Cohen PR, Kurzrock R. Mucocutaneous paraneoplastic syndromes. Sem Oncol 1997;24:334-359.
3. Gmür R, Guggenheim B. Monoclonal antibodies for the detection of "periodontopathic" bacteria. Arch Oral Biol 1990;35:145S-151S.
4. Gmür R, Baehni PC. Serum immunoglobulin G responses to various Actinobacillus actinomycetemcomitans serotypes in a young ethnographically heterogeneous periodontitis patient group. Oral Microbiol Immunol 1997;12:1-10
5. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.
6. Lello GE, Raubenheimer E. Hodgkin's disease presenting in the maxilla. A case report, Int J Oral Maxillofac Surg 1989;18:7-9.
7. Jamshed A, Allard WF, Mourad WA, Rostom AY. Primary Hodgkin's disease of the mandible. A case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:680-684.
8. Kauzler H, Kuppers R, Hausmann ML, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from crippled germinal center B cells. J Exp Med 1996;184:1495-1505.
9. Marafioti T, Hummel M, Anagnostopoulos I, et al. Origin of nodular lymphocyte-predominance Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 1997;337:453-458.
10. Gruss HJ, Brach MA, Drexler HB, Borifer R, Mertelsmann RH, Herrmann F. Expression of cytokine genes, cytokine receptor genes and transcription factors in cultured Hodgkin and Reed-Sternberg cells. Cancer Res 1992;52:3353-3360.
11. Gruss HJ, Ulrich D, Dower SK, Herrmann F, Brach MA. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kB transcription factor. Blood 1996;6:2443-2449.
12. May MJ, Ghosh S. Signal transduction through NF-kB. Immunol Today 1998;19:80-88.
13. Durkop H, Foss HD, Demel G, Klotzbach H, Hahn C, Stein H. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells. Blood 1999;93:617-623.
14. Bargou RC, Emmerich F, Krappman D, et al. Constitutive nuclear factor-kB ReI-A activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997;100:2961-2969.
15. Maggi I, Parrouchi P, Macchia D, Bellesi G, Ronaqnari S. High numbers of DR antigens in lymphoid organs involved by Hodgkin's disease. Blood 1988;71:1503-1506.
16. Gruss HJ, Pinto A, Duyster J, Poppema S, Herrmann F. Hodgkin's disease: A tumor with disturbed immunological pathways. Immunol Today 1997;18:156-163.
17. Gruss HJ, Herrmann F, Dexler HG. Hodgkin's disease: A cytokine producing tumor. Crit Rev Oncol 1994;5:23-28.
18. Eigler A, Sinha B, Hartman G, Enders S. Taming TNF: Strategies to restrain this proinflammatory cytokine. Immunol Today 1997;18:487-492.
19. Sweeney EA, Alcoforado GAP, Nyman S, Slots J. Prevalence and microbiology of localized prepubertal periodontitis. Oral Microbiol Immunol 1987;2:65-70.
20. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: Current concepts. J Periodontol 1992;63:322-331.
21. Rams TE, Feik D, Listgarten MA, Slots J. Peptostreptococcus micros in human periodontitis. Oral Microbiol Immunol 1992;7:1-6.
22. Rams TE, Feik D, Slots J. Campylobacter rectus in human periodontitis. Oral Microbiol Immunol 1993;8: 230-235.
23. Kamma JJ, Lygidakis NA, Nakou M. Subgingival microflora and treatment in prepubertal periodontitis associated with chronic idiopathic neutropenia. A case report. J Clin Periodontol 1998;25:759-765.